NAP1L5 Promotes Nucleolar Hypertrophy and Is Required for Translation Activation During Cardiomyocyte Hypertrophy
Pathological growth of cardiomyocytes during hypertrophy is characterized by excess protein synthesis; however, the regulatory mechanism remains largely unknown. Using a neonatal rat ventricular myocytes (NRVMs) model, here we find that the expression of nucleosome assembly protein 1 like 5 (Nap1l5)...
Main Authors: | Ningning Guo, Di Zheng, Jiaxin Sun, Jian Lv, Shun Wang, Yu Fang, Zhenyi Zhao, Sai Zeng, Qiuxiao Guo, Jingjing Tong, Zhihua Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.791501/full |
Similar Items
-
Slc39a2-Mediated Zinc Homeostasis Modulates Innate Immune Signaling in Phenylephrine-Induced Cardiomyocyte Hypertrophy
by: Yu Fang, et al.
Published: (2021-11-01) -
Changes in glutamic oxaloacetic transaminase 2 during rat physiological and pathological cardiomyocyte hypertrophy
by: Xin Liu, et al.
Published: (2023-12-01) -
SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
by: Zhenzhen Li, et al.
Published: (2019-01-01) -
Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy
by: Atsuko Sugimoto, et al.
Published: (2023-08-01) -
Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy
by: Ai-Lan Chen, et al.
Published: (2012-12-01)